Other substances

1-[(1R)-3-(6-{[(Benzylamino)carbonyl]amino}-1H-indol-1-YL)-1-(hydroxymethyl)propyl]-1H-imidazole-4-carboxamide

An n-alkylindole.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Experimental

1
 Supporting references
0
 Contradictory references
1
 AI-suggested references
0
 Clinical trials

General information

1-[(1R)-3-(6-{[(Benzylamino)carbonyl]amino}-1H-indol-1-YL)-1-(hydroxymethyl)propyl]-1H-imidazole-4-carboxamide on PubChem

Synonyms

FR236913

 

Structure image - 1-[(1R)-3-(6-{[(Benzylamino)carbonyl]amino}-1H-indol-1-YL)-1-(hydroxymethyl)propyl]-1H-imidazole-4-carboxamide

C1=CC=C(C=C1)CNC(=O)NC2=CC3=C(C=C2)C=CN3CC[C@H](CO)N4C=C(N=C4)C(=O)N

Supporting references

Link Tested on Impact factor Notes Publication date
Molecular mechanism of inhibition of COVID-19 main protease by β-adrenoceptor agonists and adenosine deaminase inhibitors using in silico methods
3CLpro Small molecule In silico 		in silico 3.22

Predicted to inhibit the SARS-CoV-2 3C-like protease.

 Jan/05/2021

AI-suggested references

Link Publication date
Molecular mechanism of inhibition of COVID-19 main protease by beta-adrenoceptor agonists and adenosine deaminase inhibitors using in silico methods
Jul/06/2020
Export (.csv)